The Procter & Gamble Company (ETR:PRG)
133.56
-0.86 (-0.64%)
Sep 19, 2025, 5:35 PM CET
ETR:PRG Revenue
In the fiscal year ending June 30, 2025, The Procter & Gamble Company had annual revenue of $84.28B USD with 0.29% growth. The Procter & Gamble Company had revenue of $20.89B in the quarter ending June 30, 2025, with 1.74% growth.
Revenue
$84.28B
Revenue Growth
+0.29%
P/S Ratio
4.33
Revenue / Employee
$773.25K
Employees
109,000
Market Cap
310.94B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 84.28B | 245.00M | 0.29% |
Jun 30, 2024 | 84.04B | 2.03B | 2.48% |
Jun 30, 2023 | 82.01B | 1.82B | 2.27% |
Jun 30, 2022 | 80.19B | 4.07B | 5.35% |
Jun 30, 2021 | 76.12B | 5.17B | 7.28% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Beiersdorf Aktiengesellschaft | 9.86B |
Südzucker AG | 9.30B |
Hawesko Holding SE | 630.99M |
Leifheit Aktiengesellschaft | 247.61M |
Schloss Wachenheim AG | 446.44M |
Berentzen-Gruppe Aktiengesellschaft | 173.46M |
Veganz Group AG | 10.80M |
Tonkens Agrar AG | 21.09M |
The Procter & Gamble Company News
- 2 days ago - Dow Analyst Moves: PG - Nasdaq
- 2 days ago - Consumers set to save big! FMCG giants P&G Emami and HUL roll out rate cuts; here’s what gets cheaper - The Times of India
- 2 days ago - P&G (PG) Leads Declines Among Dow Components - GuruFocus
- 2 days ago - Wall Street Analysts Think P&G (PG) Is a Good Investment: Is It? - Nasdaq
- 3 days ago - PG Factor-Based Stock Analysis - Nasdaq
- 4 days ago - PG Quantitative Stock Analysis - Nasdaq
- 4 days ago - P&G Health appoints Shashank Srowthy as Executive Director and CFO, effective October 1 - Business Upturn
- 5 days ago - PG January 2028 Options Begin Trading - Nasdaq